000			02265 a2200649 4500
005			20250515172412.0
264		0	_c20091008
008			200910s 0 0 eng d
022			_a1352-4585
024	7		_a10.1177/1352458509105229 _2doi
040			_aNLM _beng _cNLM
100	1		_aHavrdova, E
245	0	0	_aRandomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis. _h[electronic resource]
260			_bMultiple sclerosis (Houndmills, Basingstoke, England) _cAug 2009
300			_a965-76 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAdrenal Cortex Hormones _xadministration & dosage
650	0	4	_aAtrophy
650	0	4	_aAzathioprine _xadministration & dosage
650	0	4	_aBrain _xpathology
650	0	4	_aDisability Evaluation
650	0	4	_aDisease Progression
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Therapy, Combination
650	0	4	_aHumans
650	0	4	_aImmunologic Factors _xadministration & dosage
650	0	4	_aImmunosuppressive Agents _xadministration & dosage
650	0	4	_aInjections, Intramuscular
650	0	4	_aInterferon beta-1a
650	0	4	_aInterferon-beta _xadministration & dosage
650	0	4	_aMagnetic Resonance Imaging
650	0	4	_aMultiple Sclerosis, Relapsing-Remitting _xdiagnosis
650	0	4	_aPrednisone _xadministration & dosage
650	0	4	_aProspective Studies
650	0	4	_aRecurrence
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aZivadinov, R
700	1		_aKrasensky, J
700	1		_aDwyer, M G
700	1		_aNovakova, I
700	1		_aDolezal, O
700	1		_aTicha, V
700	1		_aDusek, L
700	1		_aHouzvickova, E
700	1		_aCox, J L
700	1		_aBergsland, N
700	1		_aHussein, S
700	1		_aSvobodnik, A
700	1		_aSeidl, Z
700	1		_aVaneckova, M
700	1		_aHorakova, D
773	0		_tMultiple sclerosis (Houndmills, Basingstoke, England) _gvol. 15 _gno. 8 _gp. 965-76
856	4	0	_uhttps://doi.org/10.1177/1352458509105229 _zAvailable from publisher's website
999			_c18891363 _d18891363